Guided Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-605.0K | $-500.0K | $-1.2M | $-742.0K | $-811.0K | $-427.0K | $-1.1M | $-654.0K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $2.0K | $2.0K | $3.0K | $2.0K | $3.0K | $2.0K | $2.0K | $2.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $11.0K | $68.0K | $25.0K | $22.0K | $311.0K | $19.0K | $-13.0K | $73.0K |
| Net Cash from Operating Activities | $-319.0K | $-617.0K | $-291.0K | $-277.0K | $-169.0K | $-331.0K | $-332.0K | $-473.0K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-38.0K | $923.0K | $267.0K | $181.0K | $239.0K | $58.0K | $526.0K | $392.0K |
| Net Change in Cash | — | — | — | — | — | $-273.0K | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |